Study shows aspirin has positive effect on colon cancer

Each year, more than 140,000 Americans are diagnosed with colorectal cancer. 50,000 die.

Now, a UAB oncologist says aspirin could block tumor growth in certain patients with the disease.

A study published in Thursday's issue of the New England Journal of Medicine showed after diagnosis, patients with a certain gene mutation had more than an 80% reduction in colorectal cancer deaths after taking aspirin.

In contrast, aspirin use in patients without the mutation did not affect mortality.{}

Researchers say the study sample was small and that these findings are still preliminary.